- S
Sonoma Biotherapeutics
- Sabrina Fox-Bosetti
Sabrina Fox-Bosetti has a strong background in clinical operations and research, with experience at companies such as Sonoma Biotherapeutics, Merck, Synarc, and NCIRE. Sabrina holds a Master's in Public Health with a focus on Health Policy and Management from Columbia University Mailman School of Public Health. Their expertise and experience make their a valuable asset in the healthcare industry.
Org chart
This person is not in the org chart
Teams
Offices
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.
